Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines
Article first published online: 17 JUN 2010
© 2010 The Author. British Journal of Pharmacology © 2010 The British Pharmacological Society
British Journal of Pharmacology
Volume 161, Issue 3, pages 481–487, October 2010
How to Cite
Kast, R. (2010), Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines. British Journal of Pharmacology, 161: 481–487. doi: 10.1111/j.1476-5381.2010.00923.x
- Issue published online: 3 SEP 2010
- Article first published online: 17 JUN 2010
- Received12 February 2010Revised10 May 2010Accepted11 May 2010
Supporting Information: Teaching Materials; Fig 1 as PowerPoint slide.
|BPH_923_sm_Fig1.pptx||168K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.